Basel Medical Group earnings were -$9.5M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest BMGL earnings report on Jun 30, 2025 announced Q2 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, BMGL reported annual earnings of -$9.5M, with -558.5% growth.
Basel Medical Group Earnings Reports & History FAQ
What were Basel Medical Group's earnings last quarter?
Basel Medical Group (NASDAQ: BMGL) reported Q2 2025 earnings per share (EPS) of N/A, up N/A year over year. Total BMGL earnings for the quarter were N/A. In the same quarter last year, Basel Medical Group's earnings per share (EPS) was N/A.
Is Basel Medical Group profitable or losing money?
As of the last Basel Medical Group earnings report, Basel Medical Group is currently losing money. Basel Medical Group's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$9.50 million, a 558.49% decrease year over year.
What was BMGL's earnings growth in the past year?
As of Basel Medical Group's earnings date in Q1 2026, Basel Medical Group's earnings has grown year over year. BMGL earnings in the past year totalled -$9.50 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.